ワクチンバイアル市場：タイプ、素材、容量、用途別-2025-2030年世界予測

ワクチンバイアル市場は、2023年に6億2,996万米ドルと評価され、2024年には6億9,772万米ドルに達すると予測され、CAGR 10.84%で成長し、2030年には12億9,547万米ドルに達すると予測されています。

ワクチンバイアル市場は、ワクチンの保存に使用されるガラス製またはプラスチック製の小型容器の生産と流通を網羅しています。これらのバイアルは、ワクチンの効能を維持し、安全で効果的な送達を確保し、保管物流に対応するために極めて重要です。ワクチンバイアルの必要性は、ワクチンの効能を保護し、安全な輸送を促進し、ワクチン接種プロセスにおいて正確な投与量を送達する役割に起因しています。その用途は、病院、診療所、研究所など様々な最終用途部門に及んでいます。主な成長促進要因としては、感染症の流行の増加、COVID-19のような新たな健康上の脅威によるワクチン開発の進行、世界の予防接種プログラムの強化などが挙げられます。さらに、より安全で効率的なバイアル製造を可能にする製造プロセスの技術的進歩は、魅力的な機会を示しています。革新的なパッケージング・ソリューションに関する製薬企業との提携は、市場の地位をさらに強化する可能性があります。しかし、市場の成長は、厳しい規制要件、高い製造コスト、拡大を妨げる可能性のあるサプライチェーンの混乱などの課題に直面しています。持続可能なパッケージングに対する需要の高まりは、メーカーに環境に優しい素材の革新を迫るものであり、研究開発の潜在領域を浮き彫りにしています。生分解性素材やリサイクル可能な素材を探求し、コールドチェーン物流の効率を改善することで、技術革新の道が開かれます。さらに、ワクチン保存の完全性を高めるため、温度センサーなどのデジタル機能を組み込んだスマートバイアルの開発にもチャンスがあります。これらのイノベーションは、現在の市場の限界に対処し、持続可能性の目標に沿うことで、新たな市場を開拓し、既存の事業を強化する可能性があります。市場力学は、急速に進化する公衆衛生のニーズの中で適切であり続けるためには、絶え間ないイノベーションが重要である競合情勢を示しています。結論として、スマートバイアル技術と組み合わせた持続可能な包装材料の研究を優先することで、製薬業界が直面する高い需要要件と運用上の課題を満たしながら、長期的な事業成長を実現することができます。

市場力学：急速に進化するワクチンバイアル市場の主要市場インサイトを公開

ワクチンバイアル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 感染症の流行とワクチン需要の増加
  • ワクチン接種を推進する政府機関や民間団体のイニシアティブの高まり
• 市場抑制要因
  • ヘルスケアインフラの不足
• 市場機会
  • 高性能包装ソリューションへの嗜好の高まり
  • ワクチンの安全性を確保するためのvvmの重要性の高まり
• 市場の課題
  • ワクチンバイアルのサプライチェーンに関連する高コスト

ポーターの5つの力：ワクチンバイアル市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、ワクチンバイアル市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ワクチンバイアル市場における外部からの影響の把握

外部マクロ環境要因は、ワクチンバイアル市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ワクチンバイアル市場における競合情勢の把握

ワクチンバイアル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスワクチンバイアル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ワクチンバイアル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ワクチンバイアル市場における成功への道筋を描く

ワクチンバイアル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 感染症の蔓延とワクチンの需要の高さ
    • ワクチン接種を推進する政府や民間団体の取り組みが増加
  • 抑制要因
    • ヘルスケアインフラの不足
  • 機会
    • 高性能パッケージソリューションへの関心の高まり
    • ワクチンの安全性を確保するためのVVMの重要性の高まり
  • 課題
    • ワクチンバイアルのサプライチェーンに関連する高コスト
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ワクチンバイアル市場：タイプ別

• マルチドーズ
• 単回投与

第7章 ワクチンバイアル市場：素材別

• ガラス
• ポリマー

第8章 ワクチンバイアル市場：容量別

• 10ml
• 20ml
• 2ml
• 3ml
• 5ml

第9章 ワクチンバイアル市場：用途別

• 予防ワクチン
• 治療ワクチン

第10章 南北アメリカのワクチンバイアル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のワクチンバイアル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのワクチンバイアル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Cardinal Health, Inc.
• Catalent, Inc.
• Corning Incorporated
• DWK Life Sciences GmbH
• Elitech Technology, Inc.
• ELPRO-BUCHS AG
• EVIGENCE SENSORS Inc.
• Gerresheimer AG
• Lisaline Lifescience Technologies Pvt Ltd.
• Nipro Corporation
• Pacific Vial Manufacturing Inc.
• Schott AG
• Stevanato Group
• Temptime Corporation by Zebra Technologies Corporation
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. VACCINE VIALS MARKET RESEARCH PROCESS
• FIGURE 2. VACCINE VIALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VACCINE VIALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VACCINE VIALS MARKET DYNAMICS
• TABLE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 37. CANADA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 38. CANADA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. CHINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. CHINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 59. CHINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 60. CHINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. INDIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. INDIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 63. INDIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 64. INDIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. ITALY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ITALY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 132. ITALY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 133. ITALY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. POLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. POLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 148. POLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 149. POLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. QATAR VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. QATAR VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 152. QATAR VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 153. QATAR VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 191. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2023

The Vaccine Vials Market was valued at USD 629.96 million in 2023, expected to reach USD 697.72 million in 2024, and is projected to grow at a CAGR of 10.84%, to USD 1,295.47 million by 2030.

The vaccine vials market encompasses the production and distribution of small glass or plastic containers used to store vaccines. These vials are crucial for maintaining vaccine potency, ensuring safe and effective delivery, and accommodating storage logistics. The necessity of vaccine vials stems from their role in safeguarding vaccine potency, facilitating safe transportation, and delivering precise doses during vaccination processes. Their application spans across various end-use sectors, including hospitals, clinics, and research laboratories. Key growth drivers include the increasing prevalence of infectious diseases, ongoing vaccine development due to emerging health threats such as COVID-19, and robust immunization programs globally. Additionally, technological advancements in manufacturing processes, enabling safer and more efficient vial production, represent compelling opportunities. Collaborations with pharmaceutical companies for innovative packaging solutions can further strengthen market position. However, market growth faces challenges like stringent regulatory requirements, high manufacturing costs, and supply chain disruptions that could impede expansion. The rise in demand for sustainable packaging places pressure on manufacturers to innovate with eco-friendly materials, highlighting potential areas for research and development. Exploring biodegradable and recyclable materials, and improving the efficiency of the cold chain logistics, presents avenues for innovation. Moreover, there's an opportunity in the development of smart vials incorporating digital features, like temperature sensors, to enhance the integrity of vaccine storage. These innovations can potentially open new markets and enhance existing operations by addressing current market limitations and aligning with sustainability goals. Market dynamics indicate a competitive landscape where constant innovation is crucial for staying pertinent amid rapidly evolving public health needs. In conclusion, prioritizing research in sustainable packaging materials coupled with smart vial technology can provide long-term business growth while meeting the high-demand requirements and operational challenges faced in the pharmaceutical industry.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vaccine Vials Market

The Vaccine Vials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • High prevalence of infectious diseases and demands for number of vaccines
  • Growing initiatives from government and private organizations to advance vaccination
• Market Restraints
  • Lack of healthcare infrastructure
• Market Opportunities
  • Rising preference for high performance packaging solutions
  • Increasing importance of vvm to ensure vaccine safety
• Market Challenges
  • High-cost associated with the supply chain of vaccine vials

Porter's Five Forces: A Strategic Tool for Navigating the Vaccine Vials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vaccine Vials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vaccine Vials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vaccine Vials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vaccine Vials Market

A detailed market share analysis in the Vaccine Vials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vaccine Vials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vaccine Vials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vaccine Vials Market

A strategic analysis of the Vaccine Vials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vaccine Vials Market, highlighting leading vendors and their innovative profiles. These include Cardinal Health, Inc., Catalent, Inc., Corning Incorporated, DWK Life Sciences GmbH, Elitech Technology, Inc., ELPRO-BUCHS AG, EVIGENCE SENSORS Inc., Gerresheimer AG, Lisaline Lifescience Technologies Pvt Ltd., Nipro Corporation, Pacific Vial Manufacturing Inc., Schott AG, Stevanato Group, Temptime Corporation by Zebra Technologies Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Vaccine Vials Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Multi Dose and Single Dose.
• Based on Material, market is studied across Glass and Polymer.
• Based on Capacity, market is studied across 10ml, 20ml, 2ml, 3ml, and 5ml.
• Based on Application, market is studied across Preventive Vaccine and Therapeutic Vaccine.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High prevalence of infectious diseases and demands for number of vaccines
    • 5.1.1.2. Growing initiatives from government and private organizations to advance vaccination
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of healthcare infrastructure
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising preference for high performance packaging solutions
    • 5.1.3.2. Increasing importance of vvm to ensure vaccine safety
  • 5.1.4. Challenges
    • 5.1.4.1. High-cost associated with the supply chain of vaccine vials
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Vaccine Vials Market, by Type

• 6.1. Introduction
• 6.2. Multi Dose
• 6.3. Single Dose

7. Vaccine Vials Market, by Material

• 7.1. Introduction
• 7.2. Glass
• 7.3. Polymer

8. Vaccine Vials Market, by Capacity

• 8.1. Introduction
• 8.2. 10ml
• 8.3. 20ml
• 8.4. 2ml
• 8.5. 3ml
• 8.6. 5ml

9. Vaccine Vials Market, by Application

• 9.1. Introduction
• 9.2. Preventive Vaccine
• 9.3. Therapeutic Vaccine

10. Americas Vaccine Vials Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Vaccine Vials Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Vaccine Vials Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Cardinal Health, Inc.
• 2. Catalent, Inc.
• 3. Corning Incorporated
• 4. DWK Life Sciences GmbH
• 5. Elitech Technology, Inc.
• 6. ELPRO-BUCHS AG
• 7. EVIGENCE SENSORS Inc.
• 8. Gerresheimer AG
• 9. Lisaline Lifescience Technologies Pvt Ltd.
• 10. Nipro Corporation
• 11. Pacific Vial Manufacturing Inc.
• 12. Schott AG
• 13. Stevanato Group
• 14. Temptime Corporation by Zebra Technologies Corporation
• 15. Thermo Fisher Scientific Inc.